Skip to main content

Fluticasone (International)

In the US, Fluticasone (fluticasone/salmeterol systemic) is a member of the drug class inhaled corticosteroids and is used to treat Asthma, Asthma - Maintenance, Bronchopulmonary Dysplasia and Eosinophilic Esophagitis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D07AC17,R01AD08,R03BA05

CAS registry number (Chemical Abstracts Service)

0090566-53-3

Chemical Formula

C22-H27-F3-O4-S

Molecular Weight

445

Therapeutic Categories

Glucocorticoid

Treatment of asthma and COPD

Chemical Name

S-(Fluorometyl) 6α,9-difluoro-11β,17-dihydroxy-16α-metyl-3-oxoandrosta-1,4-diene-17β-carbotioate

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.